+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06802731

Multicenter Study of LivQ-box Parameters Using iLivTouch to Diagnose Liver Inflammation in Adults with Non-alcoholic Fatty Liver Disease

Led by Wuxi Hisky Medical Technology Co Ltd · Updated on 2025-01-31

365

Participants Needed

1

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the relationship between LivQ-box parameters carried by the iLivTouch device and liver inflammation in patients with non-alcoholic fatty liver disease NAFLD. This multicenter study includes both retrospective and prospective analysis of 240 NAFLD patients to assess how these parameters correlate with the severity of liver inflammation and to develop diagnostic cut-off values for different inflammation stages. The study collects laboratory data, iLivTouch measurements, and liver biopsy results from participants. The iLivTouch examination is performed within 14 days of the liver pathology exam to evaluate LivQ-box parameters. This observational research aims to determine the diagnostic value of these parameters for various levels of liver inflammation severity in NAFLD patients. Participants undergo assessments including the iLivTouch examination and liver biopsy, along with laboratory tests. Researchers analyze the correlation between LivQ-box parameters and liver inflammation, focusing on diagnostic accuracy and establishing cut-off values. The primary outcome measure is evaluated over 12 months, providing insights into the use of iLivTouch technology in diagnosing liver inflammation in NAFLD.

CONDITIONS

Brief Title

LivQ-box® Parameters in the Diagnosis of Liver Inflammation

Research Team

L

Lai Wei

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here